Trial Profile
Phase I study to Evaluate the Safety, tolerability and Immunogenicity of BBILs Inactivated Japanese Encephalitis Virus Vaccine in healthy volunteers. - JENVAC Phase I
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2018
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions
- Sponsors Bharat Biotech
- 26 Aug 2016 New trial record